Anthropic Board expands with Novartis CEO Vas Narasimhan

AI Impact Summary

Anthropic has appointed Vas Narasimhan to its Board of Directors through the Long-Term Benefit Trust, reflecting the company's commitment to responsible AI development and its broader public benefit mission. Narasimhan's extensive experience in the pharmaceutical industry, particularly his focus on innovation and global health, aligns with Anthropic's goals of deploying AI for the long-term benefit of humanity. This appointment strengthens the Trust's influence on the board, ensuring continued alignment with the company's mission.